Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Jia-jun Zhao, Shandong Provincial Hospital
ClinicalTrials.gov Identifier:
NCT01848171
First received: May 2, 2013
Last updated: April 13, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2023
  Estimated Primary Completion Date: July 2023 (Final data collection date for primary outcome measure)